Kodu・Aktsiate loetelu・Pulse Biosciences Inc

Pulse Biosciences Inc

Avatud

SektorTervishoid

30.28 6.06

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

27.8

Max

28.7

Põhinäitajad
By Trading Economics
Sissetulek	-1.1M -19M
Müük	137K 401K
Aktsiakasum	-0.241
Kasumimarginaal	-4,633.666
Töötajad	116
EBITDA	-1.7M -19M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+10.5% upside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	11. aug 2026

Turustatistika
By TradingEconomics
Turukapital	464M 2B
Eelmine avamishind	24.22
Eelmine sulgemishind	30.28

Uudiste sentiment

By Acuity

20%

80%

35 / 340 Pingereas Healthcare

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. juuli 2026, 22:51 UTC

Pulse Biosciences Inc shares declined in after-market trading, reversing earlier gains. No specific news was identified to explain the price movement.

20. juuli 2026, 19:26 UTC

Shares of Pulse Biosciences Inc. are lower today, reversing earlier gains amid broader market pressure from rising US Treasury yields and geopolitical uncertainties.

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

10.5% tõus

12 kuu keskmine prognoos

Keskmine 32 USD 10.5%

Kõrge 32 USD

Madal 32 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Pulse Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

35 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.